AHF representatives participate in a C20 session titled “Inclusive Democracies: Gender, Sexuality and Equal Participation.
AHF recently kicked off round two of its participation in the Civil 20 (C20) Health Working Group when representatives joined over 800 civil society advocates in Tokyo ahead of the G20 summit later this year.
“Never before have we been at such a critical junction in the realms of the global HIV/AIDS response and public health overall,” said AHF Senior Director of Global Advocacy and Policy Loretta Wong. “AHF is at the C20 to help ensure important items are presented to the G20 this June, including encouraging individual governments to do their part to honor their own policies—which is key to fully funding the Global Fund to Fight AIDS, TB and Malaria.”
Other key issues raised by AHF included supporting and empowering marginalized groups to achieve true equality within their communities, drug pricing, and ending violence against young women and girls.
“Civil society and universities must continue to make it clear to the G20 how important increased investments are for global public health,” added Dr. Jorge Saavedra, Executive Director of AHF’s Global Public Health Institute at the University of Miami and former head of Mexico’s national HIV program. “Transmittable diseases know no borders or income classifications of countries, so by working to control or eradicate key epidemics and neglected tropical diseases, along with multi-drug resistant bacteria and viruses, the G20 is helping their own citizens, in addition to those in the developing world.”
The 2019 G20 summit is scheduled for June 28-29 in Osaka, Japan where decision makers will have an opportunity to honor their past commitments to global health and ending the AIDS epidemic.
AHF’s Scientific Director of Latin America and the Caribbean Dr. Miguel Pedrola speaks at a C20 session about empowering girls and marginalized populations.
